Clinical Guidelines for Female Lower Urinary Tract Symptoms

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-07-16 03:45 GMT   |   Update On 2021-07-16 05:49 GMT
Advertisement

Japanese Clinical Guidelines for Female Lower Urinary Tract Symptoms other than urinary incontinence, consisting of a total of 212 pages hy been released and published in International Journal of Urology.

Generally Female Lower Urinary Tract Symptoms are linked with sexual function, pregnancy, delivery, and pelvic organ prolapse.

The researchers selected women above 18 years of age with some lower urinary tract symptoms. The patients who may require nursing care has a different pathology and is thus not included. These guidelines have been specially made for urologists and other health professionals who are involved in the treatment of female patients with a broad range of Lower Urinary Tract Symptoms, and contain two algorithms for "primary treatment" and "specialized treatment", respectively.

Advertisement

The clinical guidelines mainly contain two algorithms for "primary treatment" and "specialized treatment," respectively. There are total 6 chapters that address 26 clinical questions including:

(i) treatment algorithms

(ii) what are female lower urinary tract symptoms

(iii) epidemiology and quality of life

(iv) pathology and illness

(v) diagnosis

(vi) treatment.

The articles were collected using a variety of sources like the PubMed and MEDLINE mostly from 2011 to 2018 also few were articles before 2011 and after 2018 were used as needed.

The grade of recommendation was determined to reflect the discussion and agreement of committee members upon close examination of the consistency of the conclusion, effect size, applicability, and treatment characteristics, such as adverse reactions and cost, for the level of evidence drawn from the articles. (The level of the article (I to V) was determined for articles about treatment.)

Grade Description

A

This action is strongly recommended

B

This action is recommended

C

There is no clear evidence for recommending this action

C1

Performing the action is not recommended

C2

Not performing this action is recommended

D

The action can still be performed

Pending

No decision has been made regarding the grade of recommendation

Following this, there were certain therapeutic methods assigned for the above-grade recommendations.

Therapeutic method

Grade of recommendation

Lifestyle interventions

Weight loss

A

Exercise

C1

Cessation of smoking

C1

Diet (fluid consumption) intervention

C1

Management of constipation

C1

Pelvic floor muscle training

A

Bladder training/Scheduled voiding regimens

B

Miscellaneous

Vaginal cone

C1

Acupuncture

C1

Thermal sheet

C1 (not yet approved)

Hypnotherapy

Pending (not yet approved)

To summarize the clinical guidelines, when the women's symptoms majorly involve voiding and post‐micturition symptoms, specific treatment modality is advised. In case of voiding symptoms simultaneous with storage symptoms, residual urine should be measured; if the residual urine volume is less than 100 ml, then the priority should be given for diagnosis and treatment for storage symptoms, and if the volume is equal to or greater than 100 ml, then specialized treatment should be considered.

When storage symptoms are the primary condition, then the patient should be subjected to the primary treatment algorithm. While specialized treatment for refractory overactive bladder includes botulinum toxin injection and sacral nerve stimulation.

Surgical treatment is recommended for stress urinary incontinence.

Lastly, surgery may benefit pelvic organ prolapse, a type of mechanical lower urinary tract obstruction.

For more information refer to:

"Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)" by Takahashi S published in the International Journal of Urology

https://doi.org/10.1111/iju.14492


Tags:    
Article Source : the international journal of urology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News